These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29807532)

  • 21. Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE).
    Bach-Ngohou K; Giraud F; Krempf M; Bard JM
    Metabolism; 2001 Mar; 50(3):277-82. PubMed ID: 11230778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.
    Apostolou F; Gazi IF; Lagos K; Tellis CC; Tselepis AD; Liberopoulos EN; Elisaf M
    Atherosclerosis; 2010 Oct; 212(2):607-13. PubMed ID: 20594556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A-II, a Player in Multiple Processes and Diseases.
    Florea G; Tudorache IF; Fuior EV; Ionita R; Dumitrescu M; Fenyo IM; Bivol VG; Gafencu AV
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E and Atherosclerosis.
    Marais AD
    Curr Atheroscler Rep; 2021 May; 23(7):34. PubMed ID: 33970359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concept of apolipoprotein-defined lipoprotein families and its clinical significance.
    Alaupovic P
    Curr Atheroscler Rep; 2003 Nov; 5(6):459-67. PubMed ID: 14525679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans.
    Bagdade JD; Jilma B; Hudgins LC; Alaupovic P; McCurdy CE
    Lipids Health Dis; 2018 May; 17(1):127. PubMed ID: 29807532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
    Alaupovic P; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Samuelsson O
    Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
    Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
    Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humans.
    Bagdade J; Pedersen BK; Schwenke D; Saremi A; Alaupovic P
    Scand J Clin Lab Invest; 2011 Oct; 71(6):449-55. PubMed ID: 21923231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CETP-mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes.
    Bagdade JD; Knight-Gibson C; Simpson N; Gerkin R; Alaupovic P; Reardon C
    Eur J Clin Invest; 2012 Jul; 42(7):709-16. PubMed ID: 22288873
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.